Biomaterials in the Treatment of Anal Fistula: Hope or Hype?
Overview
Affiliations
Anal fistula (AF) presents a chronic problem for patients and colorectal surgeons alike. Surgical treatment may result in impairment of continence and long-term risk of recurrence. Treatment options for AFs vary according to their location and complexity. The ideal approach should result in low recurrence rates and minimal impact on continence. New technical approaches involving biologically derived products such as biological mesh, fibrin glue, fistula plug, and stem cells have been applied in the treatment of AF to improve outcomes and decrease recurrence rates and the risk of fecal incontinence. In this review, we will highlight the current evidence and describe our personal experience with these novel approaches.
Awad P, Hassan B, Awad K, Elkomos B, Nada M BMC Surg. 2023; 23(1):224.
PMID: 37559044 PMC: 10413541. DOI: 10.1186/s12893-023-02117-0.
Laser technology in proctological diseases: is it really the wave of the future?.
Solari S, Martellucci J, Annicchiarico A, Scheiterle M, Bergamini C, Prosperi P Updates Surg. 2023; 75(7):1759-1772.
PMID: 37438655 DOI: 10.1007/s13304-023-01578-5.
Dehiscence of colorectal anastomosis treated with noninvasive procedures.
Cwalinski J, Hermann J, Paszkowski J, Banasiewicz T Wideochir Inne Tech Maloinwazyjne. 2023; 18(1):128-134.
PMID: 37064554 PMC: 10091912. DOI: 10.5114/wiitm.2022.121701.
A Comparison of Different Surgical Treatments for Complex Anal Fistula: A Systematic Review.
Zahra A, Malla J, Selvaraj R, Dhanoa R, Venugopal S, Shoukrie S Cureus. 2022; 14(8):e28289.
PMID: 36176822 PMC: 9512314. DOI: 10.7759/cureus.28289.
Ramachandran R, Gunasekharan V, Pillai A, Raja S, Nair A J Minim Access Surg. 2022; 18(3):443-449.
PMID: 35708389 PMC: 9306109. DOI: 10.4103/jmas.jmas_297_21.